Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články, přehledy
PubMed
33092240
PubMed Central
PMC7589904
DOI
10.3390/cancers12103063
PII: cancers12103063
Knihovny.cz E-zdroje
- Klíčová slova
- bladder cancer, en-bloc resection, transurethral resection,
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Ten senior urologists were interrogated to develop a predictive model based on factors from which they could anticipate complex transurethral resection of bladder tumours (TURBT). Complexity was defined by consensus. Panel members then used a five-point Likert scale to grade those factors that, in their opinion, drove complexity. Consensual factors were highlighted through two Delphi rounds. Respective contributions to complexity were quantitated by the median values of their scores. Multivariate analysis with complexity as a dependent variable tested their independence in clinical scenarios obtained by random allocation of the factors. The consensus definition of complexity was "any TURBT/En-bloc dissection that results in incomplete resection and/or prolonged surgery (>1 h) and/or significant (Clavien-Dindo ≥ 3) perioperative complications". Logistic regression highlighted five domains as independent predictors: patient's history, tumour number, location, and size and access to the bladder. Receiver operating characteristic (ROC) analysis confirmed good discrimination (AUC = 0.92). The sum of the scores of the five domains adjusted to their regression coefficients or Bladder Complexity Score yielded comparable performance (AUC = 0.91, C-statistics, p = 0.94) and good calibration. As a whole, preoperative factors identified by expert judgement were organized to quantitate the risk of a complex TURBT, a crucial requisite to personalise patient information, adapt human and technical resources to individual situations and address TURBT variability in clinical trials.
Department of Urology Fundacio Puigvert 08025 Barcelona Spain
Department of Urology Hôpital Cochin APHP 75014 Paris France
Department of Urology Hôpital Edouard Herriot 69437 Lyon France
Department of Urology Institut Universitaire du Cancer 31059 Toulouse CEDEX 9 France
Department of Urology Radboud UMC 6525 GA Nijmegen The Netherlands
Department of Urology Royal Surrey County Hospital Surrey Guildford GU2 7RF UK
St Josef Klinik für Urologie Caritas Krankenhaus 93053 Regensburg Germany
Zobrazit více v PubMed
Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. PubMed DOI
Leal J., Luengo-Fernandez R., Sullivan R., Witjes J.A. Economic Burden of Bladder Cancer Across the European Union. Eur. Urol. 2016;69:438–447. doi: 10.1016/j.eururo.2015.10.024. PubMed DOI
Babjuk M., Burger M., Comperat E.M., Gontero P., Mostafid A.H., Palou J., van Rhijn B.W.G., Roupret M., Shariat S.F., Sylvester R., et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur. Urol. 2019;76:639–657. doi: 10.1016/j.eururo.2019.08.016. PubMed DOI
Pereira J.F., Pareek G., Mueller-Leonhard C., Zhang Z., Amin A., Mega A., Tucci C., Golijanin D., Gershman B. The Perioperative Morbidity of Transurethral Resection of Bladder Tumor: Implications for Quality Improvement. Urology. 2019;125:131–137. doi: 10.1016/j.urology.2018.10.027. PubMed DOI
Hollenbeck B.K., Miller D.C., Taub D., Dunn R.L., Khuri S.F., Henderson W.G., Montie J.E., Underwood W., Wei J.T., 3rd, Wei J.T. Risk factors for adverse outcomes after transurethral resection of bladder tumors. Cancer. 2006;106:1527–1535. doi: 10.1002/cncr.21765. PubMed DOI
Cumberbatch M.G.K., Foerster B., Catto J.W.F., Kamat A.M., Kassouf W., Jubber I., Shariat S.F., Sylvester R.J., Gontero P. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review. Eur. Urol. 2018;73:925–933. doi: 10.1016/j.eururo.2018.02.014. PubMed DOI
Mariappan P., Finney S.M., Head E., Somani B.K., Zachou A., Smith G., Mishriki S.F., N’Dow J., Grigor K.M., Edinburgh Urological Cancer G Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: Validation across time and place and recommendation for benchmarking. BJU Int. 2012;109:1666–1673. PubMed
Ghali F., Moses R.A., Raffin E., Hyams E.S. What factors are associated with unplanned return following transurethral resection of bladder tumor? An analysis of a large single institution’s experience. Scand. J. Urol. 2016;50:370–373. doi: 10.1080/21681805.2016.1201856. PubMed DOI
Mariappan P., Zachou A., Grigor K.M., Edinburgh Uro-Oncology Group Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur. Urol. 2010;57:843–849. doi: 10.1016/j.eururo.2009.05.047. PubMed DOI
Gan C., Patel A., Fowler S., Catto J., Rosario D., O’Brien T. Snapshot of transurethral resection of bladder tumours in the United Kingdom Audit (STUKA) BJU Int. 2013;112:930–935. doi: 10.1111/bju.12235. PubMed DOI
Prasad N.N., Muddukrishna S.N. Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C. Trials. 2017;18:123. doi: 10.1186/s13063-017-1843-5. PubMed DOI PMC
Skrzypczyk M.A., Nyk L., Szostek P., Szemplinski S., Borowka A., Dobruch J. The role of endoscopic bladder tumour assessment in the management of patients subjected to transurethral bladder tumour resection. Eur. J. Cancer Care (Engl.) 2017;26 doi: 10.1111/ecc.12431. PubMed DOI
Del Rosso A., Pace G., Masciovecchio S., Saldutto P., Galatioto G.P., Vicentini C. Plasmakinetic bipolar versus monopolar transurethral resection of non-muscle invasive bladder cancer: A single center randomized controlled trial. Int. J. Urol. 2013;20:399–403. doi: 10.1111/j.1442-2042.2012.03174.x. PubMed DOI
Pan D., Soloway M.S. The importance of transurethral resection in managing patients with urothelial cancer in the bladder: Proposal for a transurethral resection of bladder tumor checklist. Eur. Urol. 2012;61:1199–1203. doi: 10.1016/j.eururo.2012.03.018. PubMed DOI
Venkatramani V., Panda A., Manojkumar R., Kekre N.S. Monopolar versus bipolar transurethral resection of bladder tumors: A single center, parallel arm, randomized, controlled trial. J. Urol. 2014;191:1703–1707. doi: 10.1016/j.juro.2013.12.004. PubMed DOI
Wu Y.P., Lin T.T., Chen S.H., Xu N., Wei Y., Huang J.B., Sun X.L., Zheng Q.S., Xue X.Y., Li X.D. Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis. Medicine (Baltimore) 2016;95:e5372. doi: 10.1097/MD.0000000000005372. PubMed DOI PMC
Zhang K.Y., Xing J.C., Li W., Wu Z., Chen B., Bai D.Y. A novel transurethral resection technique for superficial bladder tumor: Retrograde en bloc resection. World J. Surg. Oncol. 2017;15:125. doi: 10.1186/s12957-017-1192-6. PubMed DOI PMC
Herkommer K., Hofer C., Gschwend J.E., Kron M., Treiber U. Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors. J. Urol. 2012;187:1566–1570. doi: 10.1016/j.juro.2011.12.114. PubMed DOI
Golan S., Baniel J., Lask D., Livne P.M., Yossepowitch O. Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair—Clinical characteristics and oncological outcomes. BJU Int. 2011;107:1065–1068. doi: 10.1111/j.1464-410X.2010.09696.x. PubMed DOI
Carmignani L., Picozzi S., Stubinski R., Casellato S., Bozzini G., Lunelli L., Arena D. Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy. Surg. Endosc. 2011;25:2281–2287. doi: 10.1007/s00464-010-1549-1. PubMed DOI
Zhao C., Tang K., Yang H., Xia D., Chen Z. Bipolar Versus Monopolar Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: A Meta-Analysis. J. Endourol. 2016;30:5–12. doi: 10.1089/end.2015.0410. PubMed DOI
Sugihara T., Yasunaga H., Horiguchi H., Matsui H., Nishimatsu H., Nakagawa T., Fushimi K., Kattan M.W., Homma Y. Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: A population based comparison. J. Urol. 2014;192:1355–1359. doi: 10.1016/j.juro.2014.05.100. PubMed DOI
Allard C.B., Meyer C.P., Gandaglia G., Chang S.L., Chun F.K., Gelpi-Hammerschmidt F., Hanske J., Kibel A.S., Preston M.A., Trinh Q.D. The Effect of Resident Involvement on Perioperative Outcomes in Transurethral Urologic Surgeries. J. Surg. Educ. 2015;72:1018–1025. doi: 10.1016/j.jsurg.2015.04.012. PubMed DOI
Patel H.D., Ball M.W., Cohen J.E., Kates M., Pierorazio P.M., Allaf M.E. Morbidity of urologic surgical procedures: An analysis of rates, risk factors, and outcomes. Urology. 2015;85:552–559. doi: 10.1016/j.urology.2014.11.034. PubMed DOI PMC
Avallone M.A., Sack B.S., El-Arabi A., Charles D.K., Herre W.R., Radtke A.C., Davis C.M., See W.A. Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases. J. Endourol. 2017;31:767–773. doi: 10.1089/end.2017.0056. PubMed DOI PMC
Rambachan A., Matulewicz R.S., Pilecki M., Kim J.Y., Kundu S.D. Predictors of readmission following outpatient urological surgery. J. Urol. 2014;192:183–188. doi: 10.1016/j.juro.2013.12.053. PubMed DOI
Matulewicz R.S., Pilecki M., Rambachan A., Kim J.Y., Kundu S.D. Impact of resident involvement on urological surgery outcomes: An analysis of 40,000 patients from the ACS NSQIP database. J. Urol. 2014;192:885–890. doi: 10.1016/j.juro.2014.03.096. PubMed DOI
Picozzi S., Marenghi C., Ricci C., Bozzini G., Casellato S., Carmignani L. Risks and complications of transurethral resection of bladder tumor among patients taking antiplatelet agents for cardiovascular disease. Surg. Endosc. 2014;28:116–121. doi: 10.1007/s00464-013-3136-8. PubMed DOI
De Nunzio C., Franco G., Cindolo L., Autorino R., Cicione A., Perdona S., Falsaperla M., Gacci M., Leonardo C., Damiano R., et al. Transuretral resection of the bladder (TURB): Analysis of complications using a modified Clavien system in an Italian real life cohort. Eur. J. Surg. Oncol. 2014;40:90–95. doi: 10.1016/j.ejso.2013.11.003. PubMed DOI
Valerio M., Cerantola Y., Fritschi U., Hubner M., Iglesias K., Legris A.S., Lucca I., Vlamopoulos Y., Vaucher L., Jichlinski P. Comorbidity and nutritional indices as predictors of morbidity after transurethral procedures: A prospective cohort study. Can. Urol. Assoc. J. 2014;8:E600–E604. doi: 10.5489/cuaj.1848. PubMed DOI PMC
Matulewicz R.S., Sharma V., McGuire B.B., Oberlin D.T., Perry K.T., Nadler R.B. The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: An analysis of ACS NSQIP data. Urol. Oncol. 2015;33:e19–e24. doi: 10.1016/j.urolonc.2015.05.011. PubMed DOI
Di Paolo P.L., Vargas H.A., Karlo C.A., Lakhman Y., Zheng J., Moskowitz C.S., Al-Ahmadie H.A., Sala E., Bochner B.H., Hricak H. Intradiverticular bladder cancer: CT imaging features and their association with clinical outcomes. Clin. Imaging. 2015;39:94–98. doi: 10.1016/j.clinimag.2014.10.004. PubMed DOI PMC
Gregg J.R., McCormick B., Wang L., Cohen P., Sun D., Penson D.F., Smith J.A., Clark P.E., Cookson M.S., Barocas D.A., et al. Short term complications from transurethral resection of bladder tumor. Can. J. Urol. 2016;23:8198–8203. PubMed
Cornu J.N., Herrmann T., Traxer O., Matlaga B. Prevention and Management Following Complications from Endourology Procedures. Eur. Urol. Focus. 2016;2:49–59. doi: 10.1016/j.euf.2016.03.014. PubMed DOI
Bolat D., Gunlusoy B., Degirmenci T., Ceylan Y., Polat S., Aydin E., Aydogdu O., Kozacioglu Z. Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: A prospective, randomized, controlled study. Arch. Esp. Urol. 2016;69:225–233. doi: 10.1016/S1569-9056(16)15040-7. PubMed DOI
Bansal A., Sankhwar S., Goel A., Kumar M., Purkait B., Aeron R. Grading of complications of transurethral resection of bladder tumor using Clavien-Dindo classification system. Indian. J. Urol. 2016;32:232–237. doi: 10.4103/0970-1591.185104. PubMed DOI PMC
Anderson C., Weber R., Patel D., Lowrance W., Mellis A., Cookson M., Lang M., Barocas D., Chang S., Newberger E., et al. A 10-Item Checklist Improves Reporting of Critical Procedural Elements during Transurethral Resection of Bladder Tumor. J. Urol. 2016;196:1014–1020. doi: 10.1016/j.juro.2016.03.151. PubMed DOI PMC
Konishi T., Washino S., Nakamura Y., Ohshima M., Saito K., Arai Y., Miyagawa T. Risks and complications of transurethral resection of bladder tumors in patients receiving antiplatelet and/or anticoagulant therapy: A retrospective cohort study. BMC Urol. 2017;17:118. doi: 10.1186/s12894-017-0309-0. PubMed DOI PMC
Prader R., De Broca B., Chevallier D., Amiel J., Durand M. Outcome of Transurethral Resection of Bladder Tumor: Does Antiplatelet Therapy Really Matter? Analysis of a Retrospective Series. J. Endourol. 2017;31:1284–1288. doi: 10.1089/end.2017.0587. PubMed DOI
Caras R.J., Lustik M.B., Kern S.Q., McMann L.P., Sterbis J.R. Preoperative Albumin Is Predictive of Early Postoperative Morbidity and Mortality in Common Urologic Oncologic Surgeries. Clin. Genitourin. Cancer. 2017;15:e255–e262. doi: 10.1016/j.clgc.2016.09.008. PubMed DOI
Naspro R., Lerner L.B., Rossini R., Manica M., Woo H.H., Calopedos R.J., Cracco C.M., Scoffone C.M., Herrmann T.R., de la Rosette J.J., et al. Perioperative antithrombotic therapy in patients undergoing endoscopic urologic surgery: Where do we stand with current literature? Minerva. Urol. Nefrol. 2018;70:126–136. PubMed
Suskind A.M., Zhao S., Walter L.C., Boscardin W.J., Finlayson E. Mortality and Functional Outcomes After Minor Urological Surgery in Nursing Home Residents: A National Study. J. Am. Geriatr. Soc. 2018;66:909–915. doi: 10.1111/jgs.15302. PubMed DOI PMC
Ficarra V., Novara G., Secco S., Macchi V., Porzionato A., De Caro R., Artibani W. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur. Urol. 2009;56:786–793. doi: 10.1016/j.eururo.2009.07.040. PubMed DOI
Broer T., Bal R., Pickersgill M. Problematisations of Complexity: On the Notion and Production of Diverse Complexities in Healthcare Interventions and Evaluations. Sci. Cult. (Lond.) 2017;26:135–160. doi: 10.1080/09505431.2016.1212003. PubMed DOI PMC
Werner C., Bedford T., Cooke R.M., Hanea A.M., Morales-Napoles O. Expert judgement for dependence in probabilistic modelling: A systematic literature review and future research directions. Eur. J. Operat. Res. 2017;258:801–819. doi: 10.1016/j.ejor.2016.10.018. DOI
Fernandez M.I., Brausi M., Clark P.E., Cookson M.S., Grossman H.B., Khochikar M., Kiemeney L.A., Malavaud B., Sanchez-Salas R., Soloway M.S., et al. Epidemiology, prevention, screening, diagnosis, and evaluation: Update of the ICUD-SIU joint consultation on bladder cancer. World J. Urol. 2019;37:3–13. doi: 10.1007/s00345-018-2436-y. PubMed DOI
Croskerry P. From mindless to mindful practice—Cognitive bias and clinical decision making. N. Engl. J. Med. 2013;368:2445–2448. doi: 10.1056/NEJMp1303712. PubMed DOI
Peard L., Goodwin J., Hensley P., Dugan A., Bylund J., Harris A.M. Examining and Understanding Value: The Impact of Preoperative Characteristics, Intraoperative Variables, and Postoperative Complications on Cost of Robot-Assisted Laparoscopic Radical Prostatectomy. J. Endourol. 2019;33:541–548. doi: 10.1089/end.2019.0066. PubMed DOI
Bromwich D. Plenty to worry about: Consent, control, and anxiety. Am. J. Bioeth. 2012;12:35–36. doi: 10.1080/15265161.2012.656810. PubMed DOI
Wiseman O.J., Wijewardena M., Calleary J., Masood J., Hill J.T. ’Will you be doing my operation doctor?’ Patient attitudes to informed consent. Ann. R. Coll. Surg. Engl. 2004;86:462–464. doi: 10.1308/1478708041109. PubMed DOI PMC
Boulkedid R., Abdoul H., Loustau M., Sibony O., Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: A systematic review. PLoS ONE. 2011;6:e20476. doi: 10.1371/journal.pone.0020476. PubMed DOI PMC
Leeflang M.M., Rutjes A.W., Reitsma J.B., Hooft L., Bossuyt P.M. Variation of a test’s sensitivity and specificity with disease prevalence. CMAJ. 2013;185:E537–E544. doi: 10.1503/cmaj.121286. PubMed DOI PMC
Dalgaard L.P., Zare R., Gaya J.M., Redorta J.P., Roumiguie M., Filleron T., Malavaud B. Prospective evaluation of the performances of narrow-band imaging flexible videoscopy relative to white-light imaging flexible videoscopy, in patients scheduled for transurethral resection of a primary NMIBC. World J. Urol. 2019;37:1615–1621. doi: 10.1007/s00345-018-2537-7. PubMed DOI
Cumberbatch M.G.K., Jubber I., Black P.C., Esperto F., Figueroa J.D., Kamat A.M., Kiemeney L., Lotan Y., Pang K., Silverman D.T., et al. Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018. Eur. Urol. 2018;74:784–795. doi: 10.1016/j.eururo.2018.09.001. PubMed DOI
Vollmer R.T. Multivariate statistical analysis for pathologist. Part I, The logistic model. Am. J. Clin. Pathol. 1996;105:115–126. doi: 10.1093/ajcp/105.1.115. PubMed DOI
Steyerberg E.W., Vickers A.J., Cook N.R., Gerds T., Gonen M., Obuchowski N., Pencina M.J., Kattan M.W. Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology. 2010;21:128–138. doi: 10.1097/EDE.0b013e3181c30fb2. PubMed DOI PMC